|
|
||||||||
í
ek3,

* Institute for Animal Health, Compton, Berkshire, United Kingdom; and
Institute of Pathophysiology, University of Innsbruck, Innsbruck, Austria
| Abstract |
|---|
|
|
|---|
, IL-1
, IL-2, IL-6, IL-8, IL-15, and IL-18 in thyroids from
OS birds and control CB line birds, both in the embryo just before
hatch (embryonic day 20) and at 3 and 5 days posthatch. All of these
cytokines were up-regulated compared with levels in thyroids from CB
birds, at least at some time points, with some evidence for
coordination of regulation, e.g., for the proinflammatory cytokines
IL-1
and IL-8. Only IL-15 was up-regulated at all time points. IL-15
was also shown to be up-regulated in spleens of OS birds at embryonic
day 20 and 5 days posthatch, suggesting that IL-15 is constitutively
up-regulated in this line of birds. This could explain the general
immune system hyperreactivity exhibited by OS chickens and may be a
factor driving the lymphoid infiltration of the
thyroid. | Introduction |
|---|
|
|
|---|

1+ T cells
(4). By 1 or 2 mo of age, the thyroid architecture is
almost completely destroyed (5, 6). OS chickens exhibit
general immune system hyperreactivity, believed in part to be due to
intrinsic production of cytokines, perhaps IL-2 (7). Other
immunomodulating factors in OS chickens that may contribute to SAT
include premature emigration of Th cells from the thymus to the
periphery during ontogenesis (8), an imbalance between
effector and suppressor cells (9), and a disturbed
immune-endocrine system interaction (6). Cytokines, in
particular, probably have a role in initiating and perpetuating the
disease.
Recent progress in the cloning of avian cytokines has led to the
development of reagents with which to measure cytokine production in
response to infection in the chicken. This should allow a greater
insight into the mechanisms controlling the responses of the chicken to
disease, both infectious and autoimmune, at both a cellular and
molecular level. The avian orthologues of the Th1 cytokines IFN-
,
IL-2, and IL-18 recently have been cloned
(10, 11, 12), as have the proinflammatory cytokines IL-1
(13) and IL-6 (14); IL-15 (accession no.
AF152927), which is closely related to IL-2; and the chemokine IL-8
(15, 16). The genomic sequences and gene structure for
IFN-
(17), IL-2 (18), IL-18 (P. Kaiser,
unpublished data), IL-1
(P. Kaiser, unpublished data), IL-15 (P.
Kaiser, unpublished data), and IL-8 (19) have been fully
determined. A partial genomic sequence for IL-6 has also been isolated
recently (P. Kaiser, unpublished data). Gene structure information
makes possible the design of probes and primers to specifically
quantify cytokine mRNA levels using real-time quantitative RT-PCR.
We aimed to determine the levels of mRNA of these cytokines in the thyroids of 20-day-old embryos, 3- and 5-day-old OS, and unaffected CB birds to try to determine which cytokines, if any, might be driving the initial lymphocyte infiltration of the thyroid from 7 days of age in OS birds.
| Materials and Methods |
|---|
|
|
|---|
OS leukosis-free chickens (5), bred as a closed flock homozygous for the MHC haplotype B13, were maintained under standardized conventional conditions (20) in the Central Laboratory Animal Facilities of the Medical Faculty, University of Innsbruck. Chickens of the unrelated leukosis-free inbred CB line (MHC haplotype B12) were used as a control line.
The designation of MHC haplotypes conforms to the nomenclature adopted at the International Workshop of the Chicken MHC (21). For details on the lines used, see the review by Hala and Plachy (22). To eliminate breeding errors, the MHC status of all animals was serologically determined.
Real-time quantitative RT-PCR
Cytokine mRNA levels in thyroids and spleens from OS and CB birds were quantified using a method based on that of Kaiser et al. (23).
Total RNA was prepared from pooled thyroids and spleens of five birds of each strain (OS and CB) at embryonic day 20 (E20), 3 days of age (thyroids only), and 5 days of age using Trizol reagent (Life Technologies, Gaithersburg, MD) following the manufacturers instructions. Purified RNA was stored at -70°C.
For both cytokine and 28S rRNA-specific amplification, primers and
probes were designed using the Primer Express software program (PE
Applied Biosystems, Foster City, CA). Details of the probes and primers
are given in Table I
. All cytokine probes
were designed, from the sequence of the relevant genes, to lie across
intron:exon boundaries. Cytokine probes were labeled with the
fluorescent reporter dye 5-carboxyfluorescein at the 5' end and with
the quencher
N,N,N,N'-tetramethyl-6-carboxyrhodamine
(TAMRA) at the 3' end. The 28S probe was labeled with the fluorescent
reporter dye VIC (PE Applied Biosystems) at the 5' end and with TAMRA
at the 3' end.
|
Quantification was based on the increased fluorescence detected by the
ABI PRISM 7700 Sequence Detection System due to hydrolysis of the
target-specific probes by the 5' nuclease activity of the
rTth DNA polymerase during PCR amplification. The passive
reference dye 6-carboxy-x-rhodamine, which is not involved in
amplification, was used to correct for fluorescent fluctuations,
resulting from changes in the reaction conditions, for normalization of
the reporter signal. Results are expressed in terms of the threshold
cycle value (Ct), the cycle at which the
change in the reporter dye passes a significance threshold. In this
work, the threshold values of the change in the reporter dye are as
shown in Table II
for all reactions
described.
|
| Results |
|---|
|
|
|---|
Replicate measurements on different days were highly repeatable,
with a coefficient of variation for six replicate RT-PCRs of
log10 serially diluted RNA for the different
reactions, as shown in Table II
. There was a linear relationship
between the amount of input RNA and the Ct
values for the various reactions as shown in Table II
. Regression
analyses of the Ct values generated by the
log10 dilution series gave
R2 values for all reactions in excess
of 0.98 (see Table II
for details). The increase in cycles per
log10 decrease in input RNA for each specific
reaction, as calculated from the slope of the respective regression
line, is given in Table II
.
To control for variation in sampling and RNA preparation, the
Ct values for cytokine-specific product for each
sample were standardized using the Ct value of
28S rRNA product for the same sample. The Ct
values for 28S rRNA did not alter significantly from sample to sample;
the average 28S rRNA Ct values for all samples
ranged from 9.12 to 10.46. Cytokine-specific Ct
values varied from sample to sample and from cytokine to cytokine. The
Ct values for 28S rRNA thus appeared to be
independent of cytokine production and disease. Therefore, they were
taken to be representative of the level of RNA extracted from all
samples. To normalize RNA levels between samples within an experiment,
the mean Ct value for 28S rRNA-specific product
was calculated by pooling values from all samples in that experiment.
Tube-to-tube variations in 28S rRNA Ct values
about the experimental mean were calculated. The slope of the 28S rRNA
log10 dilution series regression line was used to
calculate differences in input total RNA. Using the slopes of the
respective cytokine log10 dilution series
regression lines, the difference in input total RNA, as represented by
the 28S rRNA, was then used to adjust cytokine-specific
Ct values. Fig. 1
shows the effect of standardizing cytokine-specific
Ct values to correct for tube-to-tube variation
in RNA levels. Standardization does not dramatically alter the
distribution of the results as a whole.
|
mRNA is
down-regulated in OS E20 thyroids compared with CB E20 thyroids, it is
of equal expression at 3 days posthatch, and it is up-regulated by 5
days posthatch (Fig. 2
|
and IL-8, and at 5 days posthatch only for IL-6
(Fig. 3
|
|
Given the striking up-regulation of IL-15 mRNA in the thyroids of
OS chickens at all stages sampled in this study compared with IL-15
mRNA levels in CB thyroids, we also investigated IL-15 mRNA expression
in the spleens of E20 birds and birds 5 days posthatch. IL-15 mRNA
expression is up-regulated in both the spleen and thyroid of OS birds
at E20 and day 5 posthatch compared with CB birds (Fig. 5
).
|
| Discussion |
|---|
|
|
|---|
has been shown to be up-regulated in the thyroids of
patients suffering from Hashimotos autoimmune thyroiditis
(24, 25, 26) and in chickens after the onset of lymphoid
infiltration of the thyroid in OS birds suffering from SAT
(27). We have shown that IFN-
expression in the
embryonic thyroid before the onset of SAT in OS birds is down-regulated
compared with CB chickens and that it is only up-regulated in the
thyroid from OS birds 5 days posthatch, i.e., 2 days before the onset
of lymphoid infiltration of the thyroid. In the thyroids of 5-day-old
chicks, lymphocytes were not detected by immunohistochemistry
(5). At this age, the thyroid mainly comprises cells of
the thyroid follicular epithelium, fibroblasts, macrophages, and blood
capillaries, none of which are able, under physiological conditions, to
produce IFN-
. Transgenic mice that constitutively express IFN-
in
the thyroid follicular cells developed severe hypothyroidism
(28). In our model, the induction of expression of IFN-
mRNA in the thyroid (Fig. 2
IL-18 is not up-regulated in patients suffering from Hashimotos
thyroiditis (29), although such patients do have elevated
IFN-
levels (see above). In mammals, IL-18 has three main roles: to
induce IFN-
production (30), to enhance NK cell
activity (31), and to activate neutrophils
(32). To date, chicken IL-18 has only been shown to induce
IFN-
expression by splenocytes (12). It is interesting
to note that thyroids from E20 OS birds have elevated IL-18 mRNA levels
compared with age-matched thyroids from CB birds, suggesting that this
elevated IL-18, if resulting in bioactive protein, might be driving the
elevated IFN-
levels seen later in SAT.
Not surprisingly, considering the implication of T cell-mediated
cytotoxic processes in the pathogenesis of Hashimotos thyroiditis
after the lymphoid infiltration of the thyroid, the proinflammatory
cytokines IL-1
, IL-6, and IL-8 have all been shown to be expressed
in the thyroids of patients suffering from the disease (26, 33, 34, 35, 36). This report shows that these cytokines are expressed in
the thyroids of OS chickens before the onset of the lymphoid
infiltration. Interestingly, for two of these cytokines (IL-1
and
IL-8) the up-regulation of their mRNA is biphasic, occurring both in
the embryo (E20) and just before the onset of the lymphoid infiltration
associated with the disease (day 5 posthatch). IL-6, in contrast, is
only up-regulated 5 days posthatch.
IL-2 has been implicated in the pathogenesis of both Hashimotos thyroiditis (33, 37) and SAT (7, 38). However, IL-2 mRNA is only up-regulated in the thyroids of OS birds at 3 days posthatch and therefore seems an unlikely candidate to be driving the lymphoid infiltration of the thyroid seen from day 7 posthatch. By contrast, the closely related cytokine IL-15 is up-regulated at all points in this study. In mammals, IL-15 shares many of the biological properties of IL-2. As well as being up-regulated in the thyroid of OS birds, IL-15 is also constitutively up-regulated in the spleens of OS birds at E20 and day 5 posthatch. Therefore, IL-15 represents a good candidate for the general immune system hyperreactivity in OS birds (7) and may play a role in driving the lymphoid infiltration of the thyroid (IL-15 can be chemotactic for lymphocytes (39, 40)). There is one report of IL-15 mRNA being up-regulated in the thyroids of Hashimotos thyroiditis patients (41).
At present, a lack of IL-15-specific reagents prevents us from
investigating the role of this cytokine in SAT further. One obvious
candidate for the overexpression of IL-15 in OS chickens would be a
promoter polymorphism. However, although we have determined the gene
structure for chicken IL-15, as yet we have no information on the
promoter of chicken IL-15. Although bioactive recombinant chicken IL-15
has recently been expressed (42), as yet there are no mAbs
described for chicken IL-15. However, mAbs specific for the
-chain
of the IL-15R recently have been described (43), two of
which inhibit the proliferative effect of IL-15 on T cells. This raises
the possibility of blocking experiments in ovo and in vivo to determine
whether IL-15 has a direct role in driving SAT, although these are far
from simple in avian species because murine Abs do not fix chicken
complement.
One potential drawback of real-time quantitative PCR is that, for
cytokines, mRNA does not necessarily equate to bioactive protein. For
example, both IL-1
and IL-18 in mammals are produced initially as
propeptides, which are then cleaved into an active form by the action
of caspase-1 (44, 45, 46, 47). The same mechanism is thought to
apply for the avian orthologues of these two cytokines (12, 13). IL-15 production in mammals, in contrast, is predominantly
controlled posttranslationally, and mRNA levels may be greater than
protein levels (48, 49, 50, 51). For other cytokines, mRNA levels
correlate extremely well with bioactive protein. For example, in the
chicken, IFN-
and IL-6 mRNA levels (as measured by real-time
quantitative PCR) and protein levels (as measured by bioassays) are in
close agreement (23). However, we only have reliable
bioassays for a limited number of chicken cytokines (type I IFN,
IFN-
, IL-1
, IL-2, IL-6, and IL-18) and mAbs to even fewer (type I
IFN, IFN-
, and IL-2). Overall, real-time quantitative PCR is
currently the only method that allows us to quantify a wide variety of
avian cytokines within a particular disease model.
The question remains as to which cells in the thyroid of OS birds are expressing the cytokines we have identified in this study. To this end, we intend to develop in situ hybridization for chicken cytokines in the thyroid, which in combination with immunohistochemistry should enable us to determine the phenotype of the cells expressing various cytokine mRNA before the onset of the lymphoid infiltration.
| Acknowledgments |
|---|
í
ková and
Dr. M. Kope
n
for help with RNA isolation. | Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Pete Kaiser, Institute for Animal Health, Compton, Berkshire RG20 7NN, U.K. E-mail address: pete.kaiser{at}bbsrc.ac.uk ![]()
3 Current address: Research Institute of Animal Production, Institute of Genetics and Animal Reproduction, Hlohovská 2, 949 92 Nitra, Slovak Republic. ![]()
4 Abbreviations used in this paper: OS, obese strain; SAT, spontaneous autoimmune thyroiditis; E20, embryonic day 20; Ct, threshold cycle value; TAMRA, N,N,N,N'-tetramethyl-6-carboxyrhodamine. ![]()
Received for publication November 6, 2001. Accepted for publication February 15, 2002.
| References |
|---|
|
|
|---|
gene. J. Interferon Cytokine Res. 15:939.[Medline]
: cDNA cloning and purification of active recombinant protein. Eur. J. Biochem. 258:994.[Medline]
gene, and comparison to mammalian homologues. Gene 207:25.[Medline]
-interferon by thyroid-derived T cell clones from patients with Hashimotos thyroiditis. Clin. Exp. Immunol. 69:323.[Medline]
and the inducible nitric oxide synthase in the pathophysiology of the spontaneous autoimmune thyroiditis of the Obese strain of chicken. K. A. Schat, ed. Current Progress on Avian Immunology Research 144. American Association of Avian Pathologists, Kennett Square, PA.
in the thyroid. Proc. Natl. Acad. Sci. USA 97:1719.
production by T cells. Nature 378:88.[Medline]
-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157:3967.[Abstract]
and interleukin-6 in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders. Autoimmunity 20:75.[Medline]
in "destructive" organ-specific autoimmune disease (Hashimotos thyroiditis). Ann. NY Acad. Sci. 876:221.[Medline]
chain. Vet. Immunol. Immunopathol. 82:215.[Medline]
. J. Biol. Chem. 264:5323.
convertase activity. Proc. Natl. Acad. Sci. USA 86:5227.
-inducing factor and regulates LPS-induced IFN-
production. Nature 386:619.[Medline]
inducing factor mediated by interleukin-1
converting enzyme. Science 275:206.
chain of the interleukin-2 receptor. EMBO J. 14:3654.[Medline]
This article has been cited by other articles:
![]() |
M. A. Kutzler, T. M. Robinson, M. A. Chattergoon, D. K. Choo, A. Y. Choo, P. Y. Choe, M. P. Ramanathan, R. Parkinson, S. Kudchodkar, Y. Tamura, et al. Coimmunization with an Optimized IL-15 Plasmid Results in Enhanced Function and Longevity of CD8 T Cells That Are Partially Independent of CD4 T Cell Help J. Immunol., July 1, 2005; 175(1): 112 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rothwell, J. R. Young, R. Zoorob, C. A. Whittaker, P. Hesketh, A. Archer, A. L. Smith, and P. Kaiser Cloning and Characterization of Chicken IL-10 and Its Role in the Immune Response to Eimeria maxima J. Immunol., August 15, 2004; 173(4): 2675 - 2682. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |